迴天新材(300041.SZ):2023年在越南投建年產2600萬平米光伏背板項目 預計2024年形成產能
格隆匯1月5日丨迴天新材(300041.SZ)披露投資者關係活動記錄表顯示,2023年,公司在越南投資建設年產2600萬平米光伏背板項目,目前已經完成海外公司註冊,工廠租賃,目前正在加速設備安裝等各項工作推進,預計2024年形成產能。隨着產能的逐步建成,將更好地服務海外光伏客户,有利於進一步開拓和提升海外光伏背板市場份額,優化公司光伏背板產品生產能力及產品結構,強化公司行業競爭地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.